Back to Articles
Safety9 min readFebruary 23, 2025
Has Anyone Gotten Thyroid Cancer From Mounjaro?
Examining the thyroid cancer warning on tirzepatide medications. What the research shows and who should be concerned.
By Med Consumer Watch Team
Mounjaro carries a black box warning about thyroid C-cell tumors based on animal studies. But has anyone actually developed thyroid cancer from tirzepatide? Here's what the evidence shows.
The Black Box Warning
Why the warning exists:
• Rodent studies showed thyroid C-cell tumors with GLP-1 medications
• Required for all GLP-1 receptor agonists including tirzepatide
• Based on animal data, not human cases
• Considered a theoretical risk requiring monitoring
The black box warning is the FDA's strongest warning and indicates potential serious risks.
Human Evidence So Far
What clinical trials and post-market data show:
• No confirmed cases of medullary thyroid carcinoma (MTC) attributed to tirzepatide in trials
• Millions of patients have used GLP-1 medications
• Large observational studies haven't shown increased thyroid cancer rates
• Rodent thyroid physiology differs significantly from humans
Who Should Avoid Tirzepatide
The medication is contraindicated if you have:
- Personal history of medullary thyroid carcinoma (MTC)
- Family history of MTC
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
If you have a family history of unusual thyroid cancers, discuss this with your doctor before starting any GLP-1 medication.
Monitoring Recommendations
What to watch for:
• Lump or swelling in neck
• Difficulty swallowing
• Hoarseness that doesn't go away
• Shortness of breath
Report these symptoms promptly to your doctor.
The Bottom Line
While the theoretical risk exists based on animal studies, there's no documented evidence of humans developing thyroid cancer specifically from Mounjaro. However, the medication remains contraindicated for those with personal or family history of MTC or MEN 2. For most people, the benefits likely outweigh this theoretical risk, but discuss your individual situation with your healthcare provider.
Sources & References
- FDA - Mounjaro Prescribing Information
- Journal of Clinical Endocrinology - GLP-1 and Thyroid Safety
Medical Disclaimer
This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.